De-escalation of Antibiotic Therapy in Streptococcal Bacteremia

Principles of De-escalation

The American College of Critical Care Medicine recommends that antimicrobial therapy should be reassessed daily for potential de-escalation once culture results and susceptibility data are available, with the goal of reducing antimicrobial pressure while maintaining clinical efficacy 1, 2
The Infectious Diseases Society of America suggests that the primary objective is to reduce the broad-spectrum antimicrobial therapy to a more targeted approach, once the pathogen and its susceptibility are known, thereby minimizing the risk of resistance and adverse events 1, 2

The European Society of Clinical Microbiology and Infectious Diseases recommends that empirical combination therapy should not be administered for more than 3-5 days, with de-escalation to appropriate monotherapy as soon as susceptibility profiles are available 1
The American Heart Association suggests that transesophageal echocardiography (TEE) should be performed to exclude endocarditis in patients with signs or symptoms suggestive of endocarditis, prolonged fever, or presence of a prosthetic valve 3, 4

The Infectious Diseases Society of America recommends that uncomplicated bacteremia is characterized by the absence of endocarditis, identified and controlled source of infection, negative blood cultures after 48-72 hours of appropriate therapy, and clinical improvement with resolution of fever 3, 4, 6
The American College of Cardiology suggests that TEE is particularly important in the context of prior cardioembolic stroke to exclude concomitant endocarditis 4, 5

The European Society of Clinical Microbiology and Infectious Diseases recommends that for streptococci sensitive to penicillin, penicillin G or ceftriaxone are effective, and oral penicillin V is appropriate for step-down therapy once susceptibility is documented 1

The Infectious Diseases Society of America suggests that the total duration of therapy for uncomplicated streptococcal bacteremia is 5-10 days, which is not inferior to longer regimens 1
The American Heart Association recommends that for streptococcal endocarditis, the minimum duration of therapy is 4 weeks for penicillin-sensitive strains 6

The American College of Critical Care Medicine recommends that clinical response should be evaluated daily after de-escalation, and follow-up blood cultures should be considered to confirm eradication, especially in high-risk patients 1

The Infectious Diseases Society of America suggests that de-escalation should not be delayed once susceptibility results are available and clinical improvement is documented, and that unnecessary prolongation of intravenous therapy should be avoided 1, 2